Article
Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
BMC cancer - 18 Apr 2008
Khedhaier Achraf, Hassen Elham, Bouaouina Noureddine, Gabbouj Sallouha, Ahmed Slim Ben, Chouchane Lotfi
Abstract excerpt
BACKGROUND: Xenobiotic Metabolizing Enzymes (XMEs) contribute to the detoxification of numerous cancer therapy-induced products. This study investigated the susceptibility and prognostic implications of the CYP2E1, CYP2C19, CYP2D6, mEH and NAT2 gene polymorphisms in breast carcinoma patients. METHODS: The authors used polymerase chain reaction and restriction enzyme digestion to characterize the variation of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
